This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/chemspider/
n15http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02129/identifier/drugbank/

Statements

Subject Item
n2:DB02129
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB02129 n15:DB02129
dcterms:title
Dihydroorotic Acid
adms:identifier
n4:46508825 n9:30865 n11:DOR n12:439216 n13:628 n14:DB02129
n5:synthesisReference
Hiroshi Sugano, Ryuichi Ishida, Michio Yamamura, "Dihydroorotic acid derivative and processes for preparing the same." U.S. Patent US4665056, issued April, 1981.
n5:IUPAC-Name
n6:271B4075-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B407B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B407A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4077-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4078-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4079-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4073-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4074-363D-11E5-9242-09173F13E4C5 n6:271B4071-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4072-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4081-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4082-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B407C-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B407D-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B407F-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B407E-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4080-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
155-54-4
n5:Bioavailability
n6:271B4087-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4089-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B408A-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4086-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4085-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4088-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4076-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4083-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4084-363D-11E5-9242-09173F13E4C5